Obsidian Therapeutics, Inc. Common Stock (OBX)

Obsidian Therapeutics, Inc. Common Stock (OBX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $741M; returns 1 day +0.3%, 1 week +18.8%.

Obsidian Therapeutics is a clinical-stage biopharmaceutical company specialized in engineered tumor-infiltrating lymphocyte (TIL) cell therapies for oncology.

Groups OBX belongs to

• Recent IPOs
• Clinical Stage Biopharma
• Biotechnology
• Oncology
• Biopharmaceutical
• Cancer Therapeutics
• Autologous Cell Therapy
• Clinical Stage
• Life Sciences
• Healthcare
• Healthcare Innovation

OBX financial model: income statement, cash flow and balance sheet